Snappy newsletters. Simple Facebook sharing. Spirited comments. Sweet features are waiting… GET THEM NOW!

FDA Given New Muscle To Monitor Drugs

Senate bill requires continued scrutiny after approval

By Peter Fearon, Newser Staff

Posted May 10, 2007 5:41 AM CDT

(Newser) – The Food and Drug Administration would be given sweeping new powers to order drug recalls, regulate advertising and mandate changes in labels under a bill passed by the Senate yesterday. The bill signals a fundamental shift in the FDA's role, the New York Times reports,... Read full story »

COMMENTS

Read the comment policy

You need to Log in to Newser to comment. Don't have an account yet? Sign up now!

1 comment

A snapshot of the day's best news stories.

View Larger Grid

All Today Yesterday Pick a Date

What's Popular Now on Facebook

Cops Shoot Naked Guy Eating Man's Face on Highway

Japanese Artist Serves Up Own Cooked Genitals

New York Times (Source Grid »)

Strengthening the FDA

The FDA still remains dependent on drug company money
Washington Post

Edward Kennedy's remarks on passage of FDA Bill
Kennedy.senate.gov

What the FDA Bill says
rpc.senate.gov

FDA • drugs • drug companies • Vioxx • safety • recall

More Newser Stories

Overdose Fears Prompt Recall of Infant Drugs

Danger found in cough and cold medicines for kids under 2

(NEWSER) - Several drugmakers have recalled over-the-counter cough and cold products for infants over concerns about fatal overdoses, Reuters reports. Johnson & Johnson Wyeth and Novartis are among those recalling medicines; CVS said it will remove the products and generic equivalents. One professor took the criticism one step further: “There are really no good studies demonstrating that these medications work.” More»

FDA Panel Votes to Keep Avandia on Shelves

Controversial diabetes drug still faces heart-attack link

(NEWSER) - An FDA panel said today that GlaxoSmithKline's diabetes drug Avandia should remain in drugstores, despite earlier evidence the pill ups heart failure risks. Glaxo has defended its drug, countering that the risks associated with the popular Avandia are the same as those of other diabetes drugs. More»

Salmonella Prompts Recall of Veggie Booty

Company yanks 'healthy' snack after dozens, including kids, fall ill

(NEWSER) - A snack popular with health-conscious junk-food fans because it contains kale and spinach may also contain salmonella, according to the FDA and CDC, and the manufacturer of Veggie Booty has issued a nationwide recall. Fifty-one people, many of whom had eaten the green-colored rice and corn curlicues, reported symptoms consistent with salmonella poisoning. More»

FDA Advisory Panel Rejects Weight-Loss Drug

Possible side effects send Acomplia to the sidelines

(NEWSER) - Accomplia, a weight-loss drug marketed in 18 other countries, failed to win approval from an FDA advisory board yesterday. The 14-member panel of outside experts ruled unanimously that manufacturer Sanofi-Aventis had not dispelled concerns about the safety of the drug, whose potential side effects include suicidal thoughts, anxiety, and depression. More»

Drug Company Nemesis Strikes Again

Crusading cardiologist took on Vioxx, now Avandia, for heart risks

(NEWSER) - The doctor who helped to raise concerns about the painkiller Vioxx is back—with the study released earlier this week linking the same company's popular diabetes drug, Avandia, to higher risk of heart attacks. The Wall Street Journal looks at 58-year-old cardiologist Steven Nissen's role in identifying and publicizing drug risks. More»

NEWS FROM OUR PARTNERS

What is Newser?

Face it: there's too much news. At Newser, we choose the most thought-provoking and entertaining stories from hundreds of US and international sources and reduce them to a headline, picture, and two paragraphs. And we do it 24/7—you can come back morning, noon, night (and in between) for something new that matters. Read less, know more.

Learn more »

Partnering with: Slate

View Newser on the mobile website

FDA Given New Muscle To Monitor Drugs

Senate bill requires continued scrutiny after approval

Strengthening the FDA

FDA • drugs • drug companies • Vioxx • safety • recall

MOST POPULAR STORIES

[ By Views ]

[ By Comments ]

More Newser Stories

Overdose Fears Prompt Recall of Infant Drugs

Danger found in cough and cold medicines for kids under 2

FDA Panel Votes to Keep Avandia on Shelves

Controversial diabetes drug still faces heart-attack link

Salmonella Prompts Recall of Veggie Booty

Company yanks 'healthy' snack after dozens, including kids, fall ill

FDA Advisory Panel Rejects Weight-Loss Drug

Possible side effects send Acomplia to the sidelines

Drug Company Nemesis Strikes Again

Crusading cardiologist took on Vioxx, now Avandia, for heart risks

About Us

Site

Community

Site Maps

Tools

More News

What is Newser?